L‐Carnitine to Reduce Chemoradiotherapy‐Induced Toxicity in Head and Neck Cancer: A Randomized Study
L-carnitine can be given to HNSCC patients receiving concurrent chemoradiation to lessen treatment related toxicity, but larger, multicentric randomized trials required to substantiate this conclusion.
Authors
- Indira Yadav
- A. Arya (ORCID: https://orcid.org/0000-0002-4334-6752)
- Kamna Singh (ORCID: https://orcid.org/0009-0004-6707-0473)
- Puja Kumari
Institutions
- Government Medical College (IN)
- Sarojini Naidu Medical College (IN)
- All India Institute of Medical Sciences, Deoghar (IN)
Publication Details
- Journal
- Head & Neck
- Published
- 2025-06-19
- DOI
- https://doi.org/10.1002/hed.28221
- Primary Topic
- Head and Neck Cancer Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00